Immunotherapy in Prostate Cancer – Medscape
Cancer Therapy Advisor |
Immunotherapy in Prostate Cancer
Medscape Prostate cancer is the second leading cause of cancer death in men. Even with current therapies, many patients develop metastatic castration-resistant prostate cancer. The prognosis for these patients is poor, and there is a need for therapies to … Immunotherapy and the Future of Prostate Cancer Treatment |
